Načítá se...
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Clinical and preclinical studies suggest that dysfunction of the glutamatergic system is implicated in mood disorders such as major depressive disorder (MDD) and bipolar depression. In clinical studies of individuals with MDD and bipolar depression, rapid reductions in depressive symptoms have been...
Uloženo v:
| Vydáno v: | Drugs |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342919/ https://ncbi.nlm.nih.gov/pubmed/28194724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-017-0702-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|